Ping An Health and Medtronic have announced a strategic partnership at the 7th China International Import Expo (CIIE), focusing on enhancing cardiac health, chronic disease management, and medical training. This collaboration aims to leverage the strengths of both companies to deliver innovative, high-quality, and affordable healthcare solutions to a broader population in China.
Results for: Medtronic
Medtronic has issued a Class I recall for its MiniMed 600 and 700 insulin pumps due to potential battery life issues. The recall comes after reports of shortened battery life, possibly caused by drops or impacts. Medtronic advises users to closely monitor battery alerts and carry extra batteries as a precaution.
CNBC’s ‘Halftime Report Final Trades’ featured several compelling stock picks from financial experts. Joshua Brown of Ritholtz Wealth Management highlighted 3M, while Kevin Simpson of Capital Wealth Planning favored Visa. Jenny Van Leeuwen Harrington of Gilman Hill Asset Management, LLC suggested Medtronic, and Liz Young of SoFi recommended the Invesco S&P 500 High Dividend Low Volatility ETF. The segment also included price action updates and recent analyst ratings for these companies.
Medtronic has issued a recall for certain McGrath MAC and MAC EMS Video Laryngoscopes due to a potential battery explosion risk. The recall also includes updated instructions for other models. Separately, Baxter International is recalling certain components for its Volara System due to potential issues with the handset plug disconnecting from the ventilator adapter.
Medtronic, a leading medical device company, is set to report its first-quarter fiscal 2025 earnings on August 20th. While the company faces challenges from rising costs and currency fluctuations, its underlying business remains strong with several growth drivers. This report examines the key factors that will likely influence Medtronic’s Q1 performance.
Medtronic, a leading medical device manufacturer, exceeded first-quarter 2025 earnings expectations, driven by strong performance across multiple franchises. The company also raised its full-year guidance, citing continued growth from new product launches and investments.